Moreover, lncPOIR suppresses sorafenib sensitivity and enhances HCC development by acting as a sponge for miR-182-5p, inhibiting the miR-182-5p expression, and inducing EMT. This evidence concerns the gene LNCPOIR and hepatocellular carcinoma.